These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 830753)

  • 1. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
    Kreth HW; Wiegand G
    J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
    Kreth WH; Käckell MY; ter Meulen V
    J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological response of subacute sclerosing panencephalitis patients to measles virus.
    Madden DL; Fuccillo DA; Castellano G; Traub R; Krezlewicz A; Sever JL
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):509-20. PubMed ID: 616551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; Jacobson S; McFarlin DE; McFarland HF
    Ann Neurol; 1989 Mar; 25(3):272-80. PubMed ID: 2786368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines].
    Kuwajima S
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus.
    Wechsler SL; Weiner HL; Fields BN
    J Immunol; 1979 Aug; 123(2):884-9. PubMed ID: 458157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis.
    Steele RW; Fuccillo DA; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1976 Jan; 88(1):56-62. PubMed ID: 812971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous cytotoxicity against measles virus infected and K562 cells in normal subjects and subacute sclerosing panencephalitis.
    Sanal O; Ustaçelebi S; Başaran M; Aysun S; Ersoy F; Berkel AI
    Boll Ist Sieroter Milan; 1985; 64(5):400-3. PubMed ID: 4091977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
    Santoli D; Trinchieri G; Lief FS
    J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute sclerosing panencephalitis (SSPE).
    Lapointe N; Geoffroy G; McLaughlin B; Mongeau JG
    Birth Defects Orig Artic Ser; 1975; 11(1):239-43. PubMed ID: 1096980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles-specific IgG in CSF and serum from patients with subacute sclerosing panencephalitis.
    Mehta PD; Patrick BA; Thormar H
    Immunology; 1982 Jun; 46(2):423-8. PubMed ID: 7084997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific cytolytic activity of human lymphocytes following vaccination with vaccinia virus and measles virus].
    Perrin LH; Du Pan RM; Lambert PH
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1966-9. PubMed ID: 571140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1975 Apr; 141(4):761-74. PubMed ID: 1092789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE.
    Trudgett A; Bellini WJ; Mingioli ES; McFarlin DE
    Clin Exp Immunol; 1980 Mar; 39(3):652-6. PubMed ID: 6991172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological mechanisms controlling measles virus infection.
    Cernescu C
    Virologie; 1981; 32(1):41-55. PubMed ID: 6171091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D; Trinchieri G; Koprowski H
    J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.